Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.
3.

Expression of epidermal growth factor (EGF)/transforming growth factor-alpha by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice.

Wu W, O'Reilly MS, Langley RR, Tsan RZ, Baker CH, Bekele N, Tang XM, Onn A, Fidler IJ, Herbst RS.

Mol Cancer Ther. 2007 Oct;6(10):2652-63. Epub 2007 Oct 3.

4.

Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine.

García B, Neninger E, de la Torre A, Leonard I, Martínez R, Viada C, González G, Mazorra Z, Lage A, Crombet T.

Clin Cancer Res. 2008 Feb 1;14(3):840-6. doi: 10.1158/1078-0432.CCR-07-1050.

5.

Single molecule force spectroscopy for in-situ probing oridonin inhibited ROS-mediated EGF-EGFR interactions in living KYSE-150 cells.

Pi J, Jin H, Jiang J, Yang F, Cai H, Yang P, Cai J, Chen ZW.

Pharmacol Res. 2017 May;119:479-489. doi: 10.1016/j.phrs.2016.11.036.

PMID:
28411855
6.

Quantitative analysis of ligand-EGFR interactions: a platform for screening targeting molecules.

Kuo WT, Lin WC, Chang KC, Huang JY, Yen KC, Young IC, Sun YJ, Lin FH.

PLoS One. 2015 Feb 27;10(2):e0116610. doi: 10.1371/journal.pone.0116610. eCollection 2015. Erratum in: PLoS One. 2015;10(4):e0124981.

7.

Epidermal growth factor-dependent dissociation of CrkII proto-oncogene product from the epidermal growth factor receptor in human glioma cells.

Katayama H, Hashimoto Y, Kiyokawa E, Nakaya M, Sakamoto A, Machinami R, Kurata T, Mochizuki N, Matsuda M.

Jpn J Cancer Res. 1999 Oct;90(10):1096-103.

PMID:
10595738
8.
9.

Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type.

VanMeter AJ, Rodriguez AS, Bowman ED, Jen J, Harris CC, Deng J, Calvert VS, Silvestri A, Fredolini C, Chandhoke V, Petricoin EF 3rd, Liotta LA, Espina V.

Mol Cell Proteomics. 2008 Oct;7(10):1902-24. doi: 10.1074/mcp.M800204-MCP200. Epub 2008 Aug 6.

10.

Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization.

Liu Y, Li R, Ladisch S.

J Biol Chem. 2004 Aug 27;279(35):36481-9. Epub 2004 Jun 23.

11.

G Protein betagamma subunits augment UVB-induced apoptosis by stimulating the release of soluble heparin-binding epidermal growth factor from human keratinocytes.

Seo M, Lee MJ, Heo JH, Lee YI, Kim Y, Kim SY, Lee ES, Juhnn YS.

J Biol Chem. 2007 Aug 24;282(34):24720-30. Epub 2007 Jun 4.

12.

Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-catenin, and epidermal growth factor receptor in cervical cancer cells.

Moon HS, Choi EA, Park HY, Choi JY, Chung HW, Kim JI, Park WI.

Gynecol Oncol. 2001 Jun;81(3):355-9.

PMID:
11371122
13.

Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process.

Sen T, Chatterjee A.

Eur J Nutr. 2011 Sep;50(6):465-78. doi: 10.1007/s00394-010-0158-z. Epub 2010 Dec 19.

PMID:
21170718
14.

Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.

Swindle CS, Tran KT, Johnson TD, Banerjee P, Mayes AM, Griffith L, Wells A.

J Cell Biol. 2001 Jul 23;154(2):459-68.

15.

Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells.

Song JY, Lee SW, Hong JP, Chang SE, Choe H, Choi J.

Cancer Lett. 2009 Oct 8;283(2):135-42. doi: 10.1016/j.canlet.2009.03.034. Epub 2009 Apr 19.

PMID:
19380191
16.
17.
18.

EGF-dependent and independent programmed cell death pathways in NCI-H596 nonsmall cell lung cancer cells.

Lei W, Mayotte JE, Levitt ML.

Biochem Biophys Res Commun. 1998 Apr 28;245(3):939-45.

PMID:
9588219
19.

Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.

Diermeier S, Horváth G, Knuechel-Clarke R, Hofstaedter F, Szöllosi J, Brockhoff G.

Exp Cell Res. 2005 Apr 1;304(2):604-19. Epub 2005 Jan 21.

PMID:
15748904

Supplemental Content

Support Center